Table 1 The numbers of cancer-related and neutral SAVs for each wild-type (WT) residue and the total (bolded) in our training and independent datasets.
From: The structure-based cancer-related single amino acid variation prediction
WT | Training set | Independent set 30 | Independent set 40 | |||||
|---|---|---|---|---|---|---|---|---|
Cancer | Neutral | Total | Ratio (δ) | Cancer | Neutral | Cancer | Neutral | |
ALA | 187 | 657 | 844 | 0.2846 | 12 | 191 | 26 | 268 |
CYS | 45 | 97 | 142 | 0.4639 | 6 | 21 | 9 | 36 |
ASP | 216 | 412 | 628 | 0.5243 | 14 | 121 | 26 | 167 |
GLU | 254 | 408 | 662 | 0.6225 | 11 | 114 | 27 | 174 |
PHE | 85 | 127 | 212 | 0.6693 | 9 | 46 | 14 | 58 |
GLY | 236 | 437 | 673 | 0.5400 | 11 | 129 | 21 | 171 |
HIS | 77 | 188 | 265 | 0.4096 | 6 | 63 | 9 | 85 |
ILE | 116 | 437 | 553 | 0.2654 | 5 | 113 | 9 | 178 |
LYS | 98 | 263 | 361 | 0.3726 | 6 | 98 | 12 | 131 |
LEU | 178 | 321 | 499 | 0.5545 | 6 | 99 | 17 | 141 |
MET | 63 | 202 | 265 | 0.3119 | 2 | 56 | 12 | 83 |
ASN | 90 | 340 | 430 | 0.2647 | 5 | 107 | 8 | 153 |
PRO | 200 | 363 | 563 | 0.5510 | 9 | 100 | 24 | 134 |
GLN | 83 | 212 | 295 | 0.3915 | 7 | 55 | 14 | 78 |
ARG | 328 | 1,248 | 1,576 | 0.2628 | 14 | 335 | 30 | 459 |
SER | 217 | 432 | 649 | 0.5023 | 12 | 131 | 25 | 176 |
THR | 150 | 505 | 655 | 0.2970 | 7 | 146 | 13 | 203 |
VAL | 156 | 695 | 851 | 0.2245 | 7 | 236 | 16 | 315 |
TRP | 24 | 42 | 66 | 0.5714 | 1 | 14 | 3 | 22 |
TYR | 64 | 176 | 240 | 0.3636 | 4 | 65 | 7 | 95 |
TOTAL | 2,867 | 7,562 | 10,429 | 0.3791 | 154 | 2,240 | 322 | 3,127 |